Fundz

Neurolief Announces Strategic Equity Investment By Sawai Group Holdings

PRIVATEDec 28, 2023

Round Type

Venture

TampaBiotechnologyHealth CareMedicalMedical Equipment Manufacturing

Investors

NeuroliefSawai Group Holdings Co.

Description

Neurolief, a global leader in medical devices delivering groundbreaking neurotechnology innovations for the treatment of Neurological and Neuropsychiatric disorders, is pleased to announce a strategic equity investment from Sawai Group Holdings Co., Ltd. This investment solidifies the strategic collaboration between Neurolief and the Japanese pharmaceutical corporation which have previously entered into an exclusive agreement for the development and marketing of Neurolief's Relivion® - a pioneering non-invasive, at-home wearable electroceutical therapy for migraine and depression, in Japan.

Quick answer

Neurolief raised an undisclosed amount in a funding round, dated December 28, 2023. Investors: Neurolief and Sawai Group Holdings Co. Neurolief is based in Tampa, Florida, United States.

How much did Neurolief raise?
Neurolief raised an undisclosed amount in a funding round on December 28, 2023.
Who invested in Neurolief?
Neurolief and Sawai Group Holdings Co. are named as investors in this round.
What does Neurolief do?
Neurolief develops proprietary digital therapeutics neuromodulation technology to treat neurological and neuropsychiatric disorders such as migraine and depression.
Where is Neurolief based and how big is it?
Neurolief is based in Tampa, Florida, United States.

Source: Fundz verified event record.

Who else raised in Medical and Medical Equipment Manufacturing around the same time

Companies in the same sectors as Neurolief that raised within 45 days of this round, from Fundz verified event records.

  • Motif Neurotech raised $19M (Series A) on January 24, 2024.
  • Motif Neurotech raised $15M on January 12, 2024.
  • EndoSound raised $50K (Seed) on February 9, 2024.
  • Adverum Biotechnologies raised $128M on February 7, 2024.
  • Elemind raised $12M (Funding Round) on February 6, 2024.
  • Greenbrook TMS raised $1.5M (Seed) on February 6, 2024.

Who to call at Neurolief, and when

A new round usually means Neurolief is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Neurolief raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Neurolief, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Neurolief. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Neurolief

Location

Tampa, Florida, United States

About

Neurolief develops proprietary digital therapeutics neuromodulation technology to treat neurological and neuropsychiatric disorders such as migraine and depression. The company’s devices either complement or provide an alternative to pharmaceutical therapies, which are often ineffective and are associated with potential short- and long-term adverse effects. Neurolief’s products are groundbreaking electronic head mounted devices designed to concurrently target major neural pathways in the head and thereby affect brain regions that are involved in control and modulation of pain and mood. These devices are intended to provide a highly effective, side-effects free treatment for the hundreds of millions of patients worldwide. Neurolief is led by a seasoned team with extensive experience and successful track record developing multiple neuromodulation devices for patients with central nervous system deficiencies.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Neurolief raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for Neurolief's next move

See what Strategic adds

Neurolief raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.